Svb Leerink Begins Coverage on Livongo Health (NASDAQ:LVGO)

Share on StockTwits

Svb Leerink initiated coverage on shares of Livongo Health (NASDAQ:LVGO) in a research report sent to investors on Monday, BenzingaRatingsTable reports. The firm issued an outperform rating and a $50.00 price target on the stock.

Several other analysts have also commented on the stock. Needham & Company LLC initiated coverage on shares of Livongo Health in a report on Monday. They issued a buy rating and a $42.00 price objective for the company. JPMorgan Chase & Co. initiated coverage on shares of Livongo Health in a report on Monday. They issued an overweight rating and a $43.00 price objective for the company. Leerink Swann initiated coverage on shares of Livongo Health in a report on Monday. They issued an outperform rating and a $50.00 price objective for the company. Piper Jaffray Companies initiated coverage on shares of Livongo Health in a report on Monday. They issued an overweight rating and a $40.00 price objective for the company. Finally, Chardan Capital initiated coverage on shares of Livongo Health in a report on Friday, August 16th. They issued a neutral rating and a $40.00 price objective for the company. Two analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. Livongo Health presently has an average rating of Buy and a consensus price target of $44.20.

Livongo Health stock opened at $34.95 on Monday. Livongo Health has a 1-year low of $31.60 and a 1-year high of $45.68.

In other Livongo Health news, Director Hemant Taneja bought 2,678,571 shares of the firm’s stock in a transaction on Monday, July 29th. The stock was acquired at an average price of $28.00 per share, with a total value of $74,999,988.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, major shareholder Ab (Publ) Kinnevik bought 3,141,795 shares of the firm’s stock in a transaction on Monday, July 29th. The shares were acquired at an average cost of $28.00 per share, with a total value of $87,970,260.00. The disclosure for this purchase can be found here.

Livongo Health Company Profile

Livongo Health, Inc provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications.

Featured Article: How Important is Technical Analysis of Stocks

Analyst Recommendations for Livongo Health (NASDAQ:LVGO)

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Circassia Pharmaceuticals  Rating Reiterated by Peel Hunt
Circassia Pharmaceuticals Rating Reiterated by Peel Hunt
Baader Bank Analysts Give SAP  a €120.00 Price Target
Baader Bank Analysts Give SAP a €120.00 Price Target
Sartorius  Given a €184.00 Price Target by UBS Group Analysts
Sartorius Given a €184.00 Price Target by UBS Group Analysts
US Capital Advisors Comments on Centennial Resource Development Inc’s Q3 2019 Earnings
US Capital Advisors Comments on Centennial Resource Development Inc’s Q3 2019 Earnings
Q3 2019 Earnings Estimate for Delphi Technologies PLC  Issued By Jefferies Financial Group
Q3 2019 Earnings Estimate for Delphi Technologies PLC Issued By Jefferies Financial Group
Associated Banc  to Release Earnings on Thursday
Associated Banc to Release Earnings on Thursday


 
© 2006-2019 Zolmax.